Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;24(6):909-15.
doi: 10.1007/s11695-014-1191-4.

Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance

Marek Bužga  1 , Machytka Evžen, Klvaňa Pavel, Kupka Tomáš, Zavadilová Vladislava, Zonča Pavel, Zdeněk Svagera
Affiliations

Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance

Marek Bužga et al. Obes Surg. 2014 Jun.

Abstract

Background: The prevalence of obesity continues to increase worldwide. Because obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. Although various treatments are currently available, many are not efficacious in the long term. Therefore, additional medical treatment options for morbidly obese individuals must be explored. In this study, we examined the effects of the intragastric balloon MedSil on anthropometric measures and hormones associated with lipid and energy metabolism.

Methods: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil following a clinical exam, body composition scan, and collection of blood samples. Six months following implantation of the balloon, additional anthropometric and serological measures were taken.

Results: Six months following insertion of the MedSil balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21, and glycated hemoglobin levels significantly decreased, 6 months after balloon insertion.

Conclusions: The MedSil intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The intragastric balloon MedSil® used in endoscopic treatment for morbidly obese patients
Fig. 2
Fig. 2
A system of tubes for saline solution in endoscopic treatment of the intragastric balloon MedSil®
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Obesity and overweight, Factsheet N°311, 2011March [cited 2013 Jul 30]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
    1. Ackroyd R, Mouiel J, Chevallier JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16(11):1488–1503. doi: 10.1381/096089206778870067. - DOI - PubMed
    1. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107(10):1755–1767. doi: 10.1016/j.jada.2007.07.017. - DOI - PubMed
    1. Avenell A, Brown TJ, McGee MA, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet. 2004;17(4):317–335. doi: 10.1111/j.1365-277X.2004.00531.x. - DOI - PubMed
    1. Konopko-Zubrzycka M, Baniukiewicz A, Wróblewski E, et al. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab. 2009;94(5):1644–1649. doi: 10.1210/jc.2008-1083. - DOI - PubMed

Publication types